Trial Profile

International Study With Nexavar About Safety and Efficacy in Carcinoma Hepatocellular Therapy (HCC)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 22 Jul 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sorafenib (Primary)
Indications Liver cancer
Focus Therapeutic Use
Acronyms INSIGHT
Sponsors Bayer

Most Recent Events

11 Jul 2017 Results published in the Clinical cancer research: an official journal of the American Association for Cancer Research.
24 Sep 2014 According to a Bayer HealthCare media release, results from this trial will be presented at the European Society for Medical Oncology (ESMO) 2014 Congress.
13 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com